City of Hope has so many breakthroughs in cancer, diabetes and HIV/AIDS - and so many stories - that we've tailored our blog, Breakthroughs, to provide something for every reader. Whether the breakthroughs are about medical research, treatment advances or personal triumphs, they're all connected.
July 10, 2017 | Stephanie Smith
When viewed under a microscope, T cells - sentinels of the immune system whose job inside the body is to seek out foreign invaders - quiver as they surround and consume cancer cells. They were genetically modified in a lab by City of Hope researchers and trained to target specific receptors on patients’ brain tumors - part of an emerging approach to cancer care called immunotherapy.
July 7, 2017 | Samantha Bonar
Sunita Patel, Ph.D., a neuropsychologist in the Population Sciences and Supportive Care Medicine departments at City of Hope, has received a $1.22 million grant from the American Cancer Society to test a new approach toward preventing long-term chemotherapy-related cognitive side effects in childhood cancer survivors from bilingual and Spanish-speaking families.
January 4, 2017 | Stephanie Smith
Sketches of a brain surgery performed on B., one of several patients in a breakthrough clinical trial for brain cancer at City of Hope. Early results of the trial — describing promising results using CAR-T cells for a 50-year-old patient with an aggressive brain cancer called glioblastoma multiforme — were published recently in the New England Journal of Medicine.
December 7, 2016 | City of Hope
Numerous clinical trials, which lay the groundwork for novel approaches to lymphoma and multiple myeloma therapies, could ultimately lead to new treatments that improve survival and quality of life for patients with those and other diseases. Additional studies give new insight into best practices for the treatment of various blood cancers.
December 1, 2016 | City of Hope
In this Q and A, Steven T. Rosen, M.D., provost and chief scientific officer for City of Hope, answers questions about the importance of precision of medicine in the fight against cancer and how the City of Hope and TGen alliance will advance research and treatment using this approach.
November 15, 2016 | Travis Marshall
For most people diagnosed with thyroid cancer, treatment is a relatively straightforward combination of surgery and radioactive iodine treatment. But that is not always the case. Behrouz Salehian, M.D., discusses the different ways to treat this disease.
September 22, 2016 | Letisia Marquez
The novel cell therapies will be used in preclinical trials funded by the National Heart, Lung, and Blood Institute.
July 21, 2016 | City of Hope
At City of Hope, at least 400 clinical trials are going on at any given time. To help illuminate the clinical trial process for patients, here are five facts you may not have known.
July 18, 2016 | City of Hope
Study, published in Blood, reports on five-year survival data, suggests targeted therapy should be standard of care for patients with relapsed or treatment-resistant Hodgkin lymphoma.